Search the webpage

Director In Vivo Pharmacology. Location: Headquarters, Kuopio, Finland.

Director In Vivo Pharmacology. Location: Headquarters, Kuopio, Finland.


Dr. Cerrada-Gimenez obtained his PhD in Biotechnology from the A.I. Virtanen Institute at the University of Eastern Finland in 2011. Shortly thereafter, Marc joined Charles River Discovery Services (Kuopio, Finland), where he led the Biomarker and in vitro team designing and leading multiple projects, which aimed at studying various neurodegenerative indications.

In 2016, he joined the biotech Minoryx Therapeutics as Head of Biomarker Discovery collaborating in the development of compounds for the treatment of rare diseases, with the most advanced candidate currently undergoing Phase II-III. During that time he acquired experience in the preparation and submission of regulatory documents for the EMA and FDA.



Marc Gimenez


In vivo imaging in the rat oxygen-induced retinopathy model

Oxygen-induced retinopathy model as an experimental model for retinopathy of prematurity and human ischemic retinopathies ... Read More

Are antioxidants the solution to burning and itchy eyes?

A recently published study in The Ocular Surface journal authored by Experimentica Ltd. in collaboration with researchers from Loyola University ... Read More

A summary of 2018 and a preview of 2019

An overview of main activities and advancements at Experimentica Ltd. in 2018 ... Read More

Subscribe to Our Newsletter!

We promise that no sales pitches will be attached to newsletter. And don't worry, we hate spammers too!